InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Balkin Michael, Chief Executive Officer. Officer active across 2 companies, notably Foresight Acquisition Corp.. In total, 6 disclosures have been recorded. Total volume traded: €168k. The latest transaction was filed on 28 January 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€64,99515,000 shares@ €4.3330.0028% mcap38.7% of flow
Class A Common Stock
SEC:0001213900-22-004459:0·
Ideal exit: 25 Oct 2022 (T+270)
€64,99515,000 shares@ €4.3330.0028% mcap77.3% of flow
Class A Common Stock
SEC:0001213900-22-004459·
Ideal exit: 25 Oct 2022 (T+270)
€19,0824,239 shares@ €4.50150.0008% mcap11.3% of flow
Class A Common Stock
SEC:0001213900-22-003127:0·
Ideal exit: 16 Oct 2022 (T+270)
€19,0824,239 shares@ €4.50150.0008% mcap22.7% of flow
Class A Common Stock
SEC:0001213900-22-003127·
Ideal exit: 16 Oct 2022 (T+270)
6,843,525 shares
Class A Common Stock
SEC:0000899243-21-039472·
6,843,525 shares
Class A Common Stock
SEC:0000899243-21-039472:0·
6 of 6 declarations
About Balkin Michael
Michael Balkin is the Chief Executive Officer of Foresight Acquisition Corp. and P3 Health Partners Inc. He leads the operations of these companies and is responsible for overall strategy. Michael is committed to promoting sustainable growth and ensuring the company's success.
